NCT07279779Completed
HypnoDiaCare Trial: A Randomized Controlled Study of Hypnosis-Integrated Diabetes Self-Management Intervention
A Three-Arm Randomized Controlled Trial Evaluating the Efficacy of HypnoDiaCare, an Integrative Hypnosis-Based Diabetes Self-Management Intervention, Compared With EduDiaCare and Neutral Visual Attention Control Among Adults With Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
This study evaluated the efficacy of HypnoDiaCare, a two-session integrative intervention that combines clinical hypnosis with diabetes self-management education based on the AADE7 Self-Care Behaviors framework, for adults with type 2 diabetes mellitus (T2DM). The trial used a three-arm randomized controlled design with HypnoDiaCare, EduDiaCare (education-only), and a neutral visual attention control group. All participants completed two individual sessions over a 1-2-week interval and completed pretest and posttest assessments. HypnoDiaCare integrates hypnotic induction, guided imagery, ego strengthening, and positive suggestions with diabetes self-management principles. EduDiaCare provides structured education without hypnosis, and the control group viewed neutral images designed to maintain stable emotional and physiological states. After the initial posttest, control-group participants were re-randomized to receive HypnoDiaCare or EduDiaCare to explore delayed-intervention effects. Primary outcomes were diabetes self-management and quality of life, while secondary outcomes included psychological symptoms and affective states. The study aims to determine whether HypnoDiaCare produces greater improvements in self-management and quality of life compared with education-only and attention-control conditions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 1 Dec 2025
- Start date
- 23 Dec 2024
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Gadjah Mada University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07279779
What you commit to
- Study type: Interventional
- Participants enrolled: 54
- From 23 Dec 2024 to the primary completion date, 31 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of severe psychiatric disorders as self-reported
- Severe physical illness or comorbidities that may interfere with participation
- Cognitive impairment that may hinder comprehension or procedure adherence
- Failure to attend both intervention sessions
- Any condition judged by the investigators to interfere with safe participation
Other
- Currently undergoing psychological treatment or psychotherapy
Who the study is looking for
- Adults aged 20 years or older
- Diagnosed with type 2 diabetes mellitus (T2DM), confirmed via self-report or written recommendation from Puskesmas based on medical records
- Able to read and understand Indonesian
- Not currently receiving psychological therapy
- Willing to attend two intervention sessions
- Provided written informed consent
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hypnotic Guided Imagery Laboratory, Faculty of Psychology, Universitas Gadjah Mada Coordinator of this site? Confirm its status | Yogyakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.